Qingdao Haier Biomedical Co.,Ltd.(688139),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

688139 Qingdao Haier Biomedical Co.,Ltd.

Closed 10-20 15:00:00

32.45

+0.55

+1.72%

High32.60	Low31.48	Vol2.31M
Open31.70	D1 Closing31.90	Amplitude3.51%
Mkt Cap10.25B	Tradable Cap10.25B	Total Shares316.00M
T/O74.04M	T/O Rate0.73%	Tradable Shares316.00M
P/B2.32	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"688139","market":"SH","secType":"STK","nameCN":"Qingdao Haier Biomedical Co.,Ltd.","latestPrice":32.45,"timestamp":1792479600000,"preClose":31.9,"halted":0,"volume":2305984,"delay":0,"changeRate":0.0172,"floatShares":316000000,"shares":316000000,"eps":0.807,"marketStatus":"Closed","change":0.55,"latestTime":"10-20 15:00:00","open":31.7,"high":32.6,"low":31.48,"amount":74040400,"amplitude":0.0351,"askPrice":32.45,"askSize":1,"bidPrice":32.42,"bidSize":73,"shortable":0,"etf":0,"ttmEps":0.807,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1792546200000},"marketStatusCode":5,"adr":0,"adjPreClose":31.9,"symbolType":"stock_kcb","openAndCloseTimeList":[[1792459800000,1792467000000],[1792472400000,1792479600000]],"highLimit":35.09,"lowLimit":28.71,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":316492922,"isCdr":false,"pbRate":2.32,"roa":"--","peRate":40.210657,"roe":"3.34%","epsLYR":0.8,"committee":-0.035129,"marketValue":10270000000,"turnoverRate":0.0073,"status":0,"afterMarket":{"amount":16225,"volume":500,"close":32.45,"buyVolume":0,"sellVolume":0,"time":1792481638801,"indexStatus":"Closed 10-20 15:30:00","preClose":31.9},"floatMarketCap":10270000000},"requestUrl":"/m/hq/s/688139","defaultTab":"news","newsList":[{"id":"2655818503","title":"Minerals Technologies Swings to Q2 Net Loss on Talc-related Litigation Charge","url":"https://stock-news.laohu8.com/highlight/detail?id=2655818503","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655818503?lang=en_us&edition=fundamental","pubTime":"2026-07-31 05:18","pubTimestamp":1785446329,"startTime":"0","endTime":"0","summary":"Minerals Technologies swings to Q2 net loss on talc-related litigation chargeOverviewUS specialty minerals firm's Q2 sales rose 4% yr/yr, missing analyst expectationsAdjusted EPS for Q2 increased 3% y","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260730:nL1N43W1PN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4011","LU2488822045.USD","688139","USLM","MTX","BK0251","BK4109"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114858584","title":"Haier Biomedical Announces Share Buyback Plan Valued Between 50 and 100 Million Yuan","url":"https://stock-news.laohu8.com/highlight/detail?id=1114858584","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114858584?lang=en_us&edition=fundamental","pubTime":"2026-07-02 16:49","pubTimestamp":1782982149,"startTime":"0","endTime":"0","summary":"Qingdao Haier Biomedical Co.,Ltd. (688139.SH) has released an announcement regarding a proposed share repurchase initiative.The company intends to utilize its own funds to repurchase shares via a...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688139","LU2488822045.USD","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198669369","title":"Haier Biomedical's Controlling Shareholder Proposes Share Buyback Program Valued Between RMB 50 Million and RMB 100 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1198669369","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198669369?lang=en_us&edition=fundamental","pubTime":"2026-06-25 18:06","pubTimestamp":1782381989,"startTime":"0","endTime":"0","summary":"The controlling shareholder of Qingdao Haier Biomedical Co.,Ltd. (SH: 688139) has submitted a formal proposal for the company to repurchase its own shares.The proposal, received by the company on...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0251","LU2488822045.USD","688139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636897210","title":"Haier Biomedical Publishes 2025 Sustainability Report: Committed to Building a Platform for Technology, Industry and Social Responsibility","url":"https://stock-news.laohu8.com/highlight/detail?id=2636897210","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636897210?lang=en_us&edition=fundamental","pubTime":"2026-05-20 12:23","pubTimestamp":1779250980,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nTUA65NMSG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["688139","BK0251","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631503922","title":"Press Release: Haier Biomedical Drives Global Leap of Life Science Infrastructure: International Business Hits Record High for 36% of Annual Revenue in 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2631503922","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631503922?lang=en_us&edition=fundamental","pubTime":"2026-04-30 12:27","pubTimestamp":1777523220,"startTime":"0","endTime":"0","summary":"AI-powered growth surges as Haier Biomedical scales from product coverage to premium brand leadership, building a global life science tools and intelligent productivity platform. QINGDAO, China, April 30, 2026 /CNW/ -- Haier Biomedical , a global leader in life sciences and medical solutions, has officially published its 2025 annual report, posting full--year revenue of 2.33 billion yuan  with overseas revenue growing 17.9% year-on-year to 840 million yuan , accounting for 36% of total revenue -- a record high. Despite a complex global trade environment, Haier Biomedical delivered double--digit growth across all international business sectors.Haier Biomedical continued to optimize its revenue structure in 2025, with new market sectors and overseas operations emerging as core engines of growth. New business segments such as smart medication, blood technology, laboratory solutions and more contributed 48.5% of total revenue, representing an 8.8% year-on-year increase.Its ultra--low and l","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4023","BK4543","BK4551","AI","AIPO","CHAT","BK4588","ARTY","AIYY","BK4587","LU2488822045.USD","688139","BK0251","BK4528","AGIX","BK4585"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1792492366332,"stockEarnings":[{"period":"1week","weight":-0.0689},{"period":"1month","weight":0.0172},{"period":"3month","weight":0.1512},{"period":"6month","weight":-0.0307},{"period":"1year","weight":-0.0274},{"period":"ytd","weight":0.016}],"compareEarnings":[{"period":"1week","weight":-0.0175},{"period":"1month","weight":-0.0463},{"period":"3month","weight":-0.0345},{"period":"6month","weight":-0.0914},{"period":"1year","weight":-0.0283},{"period":"ytd","weight":-0.0599}],"compareStock":{"symbol":"000001.SH","name":"SSE Comp"},"companyName":"青岛海尔生物医疗股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"14672人(较上一季度减少0.93%)","perCapita":"21571股","listingDate":"2019-10-25","address":"山东省青岛市城阳区高新区丰源路280号","registeredCapital":"31649万元","survey":"　　青岛海尔生物医疗股份有限公司的主营业务是为生物医药企业、高校科研机构、医院、疾控等用户提供数字化场景解决方案。公司的主要产品是智慧平台、样本存储、药品、疫苗存储、血液存储。根据全球权威调研机构欧睿国际（Euromonitor）认证，公司已经成为“全球生命科学实验室设备中国自主品牌销售额第一”及“生命科学实验室设备中国自主品牌海外销售额第一”。","listedPrice":15.53},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Qingdao Haier Biomedical Co.,Ltd.(688139),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Qingdao Haier Biomedical Co.,Ltd.(688139) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Qingdao Haier Biomedical Co.,Ltd.,688139,Qingdao Haier Biomedical Co.,Ltd.股票,Qingdao Haier Biomedical Co.,Ltd.股票老虎,Qingdao Haier Biomedical Co.,Ltd.股票老虎国际,Qingdao Haier Biomedical Co.,Ltd.行情,Qingdao Haier Biomedical Co.,Ltd.股票行情,Qingdao Haier Biomedical Co.,Ltd.股价,Qingdao Haier Biomedical Co.,Ltd.股市,Qingdao Haier Biomedical Co.,Ltd.股票价格,Qingdao Haier Biomedical Co.,Ltd.股票交易,Qingdao Haier Biomedical Co.,Ltd.股票购买,Qingdao Haier Biomedical Co.,Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Qingdao Haier Biomedical Co.,Ltd.(688139),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Qingdao Haier Biomedical Co.,Ltd.(688139) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction